Top 5 forecasting tips in Oncology.


All Change

Consider the stability of the market when deciding on the methodology.

Patient flow models are accurate and provide a great deal of insight, however, they’re only really necessary when there is a part or future variability across stages or lines of treatment.


Devil’s in the detail

Using pre-calculated treatable patients saves a lot of time.

However, check the data and assumptions used by your data provider. They should use up-to-date sources that are local where possible


Look before you jump

As with all forecasting, there are 3 key considerations that should be weighed against each other: value of the decision, accuracy required and the data available.

Before employing a patient flow methodology, rather than a more simplistic prevalence-based model, the forecaster should consider if the data supports the methodology, lots of complex algorithms do not deliver value if the inputs are largely assumption-based.


Does it make a difference?

Sometimes there is an urge to forecast a variable because you can, but the more detailed and complex a model is, the less value it will often bring.

So always ask the question: Does it make a difference? A good example is the inclusion of 3rd or 4th line patients, does their inclusion make any substantial difference to the final forecast? If the answer is no, then group them.


Step out of the bubble

Consider some questions:

  • How competitive is the market?
  • How much investment is required to penetrate a highly competitive market?
  • What is the distribution of potential prescribers?
  • Could the healthcare system bear the cost of the product?

For further information about Onco+, Oncology, Pharmaceutical Forecasting software click here or just book a free demo and trial of Onco+ here.

more insights

Our Pharmaceutical Forecasting Predictions for 2024

As the pharmaceutical industry contends with growing financial pressures, we examine its strategic outlook for 2024. How does the sector intend to align with projected commercial objectives while continuing to meet patient needs and what are the implications for forecasting teams?

Read more >